
KYMR
Kymera Therapeutics Inc
Biotechnology
Kymera Therapeutics Inc (KYMR) Insider Trading
15 transactions reported on SEC Form 4 — executive and director buys and sells.
Buys
0
Sells
10
Net value
$-121.3M
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Rooney Terence | Chief Medical Officer | Grant | 38,000 | — | Jul 27, 2026 |
| Mainolfi Nello | Chief Executive Officer | Exercise | 50,000 | $104.0K | Jul 7, 2026 |
| Mainolfi Nello | Chief Executive Officer | Sell | 50,000 | $6.0M | Jul 7, 2026 |
| BVF PARTNERS L P/IL | Sell | 837,914 | $89.2M | Jun 26, 2026 | |
| BVF PARTNERS L P/IL | Grant | 6,068 | — | Jun 24, 2026 | |
| Booth Bruce | Sell | 37,179 | $4.5M | Jun 25, 2026 | |
| Booth Bruce | Sell | 1,235 | $123.5K | Jun 23, 2026 | |
| Booth Bruce | Sell | 103,688 | $10.4M | Jun 24, 2026 | |
| Booth Bruce | Sell | 9,994 | $1.1M | Jun 25, 2026 | |
| Booth Bruce | Exercise | 11,741 | $234.8K | Jun 17, 2026 | |
| Booth Bruce | Sell | 18,313 | $1.9M | Jun 22, 2026 | |
| Booth Bruce | Sell | 11,741 | $1.1M | Jun 17, 2026 | |
| Booth Bruce | Sell | 62,897 | $5.7M | Jun 18, 2026 | |
| Booth Bruce | Sell | 14,921 | $1.4M | Jun 22, 2026 | |
| Jacobs Bruce N. | Chief Financial Officer | Exercise | 12,653 | $0 | Jun 2, 2026 |